implementing risk-based monitoring: a cro ......intrinsic risks maturity of safety profile phase of...
TRANSCRIPT
Confidential – For Internal Use Only
IMPLEMENTING RISK-BASED MONITORING: A CRO PERSPECTIVE
Ben Dudley, Executive Director Alliance Management, Covance Inc.
3rd Annual Clinical Trials Oversight SummitBoston, 2 June 2014
Confidential – For Internal Use Only
Topics Covered
2
RBM Process Implementation
The RBM Landscape, Drivers and Barriers
Implementation Learnings
Accessing RBM Benefits
2
Confidential – For Internal Use Only
Significant Conversion to RBM Expected
3
RBM will become the new normalSource: Industry interviews commissioned by Covance. * Note: Not a quantitative forecast
Current use of RBM solutions
Expected use of RBM solution in the next 10 years*
Expected use of RBM solution in the next 5 years*
Regulatory mandate
Development cost increases
RBM process maturation
Increased quality expectations
Traditional Monitoring ApproachesRBM
Confidential – For Internal Use Only
RBM: What Is It?
4
ID Critical Data/
Processes
ID Critical Data/
Processes
Risk Identification
Risk Identification
Primary Prevention
Primary Prevention
Active Mitigation
Active Mitigation
Quality Surveillance
Quality Surveillance
Identification and Repair
Identification and Repair
AdaptationAdaptation
Holistic; proactive; preventive; dynamic; iterative RBM is a logical next step to enhance efficiency and quality
4
• Holistically identifies risk of failure
• Designs monitoring approaches to
prevent or mitigate risk
• Differentiates critical vs. non-critical
• Delivers fit for purpose quality –
flexible to study and regulatory need
• End to end trial conduct
transformation
• An extension to smart study design
Confidential – For Internal Use Only
What Might Be Slowing Adoption of RBM?
5
6%
10%
28%
32%
34%
34%
34%
38%
46%
0% 10% 20% 30% 40% 50%
Other*
Risk/reward for RBM not sufficient
Convincing senior management of benefits of RBM
Increased risk
Lack of internal knowledge/expertise to implement RBM
Identification of risk associated with clinical trial
Greater cost
Inability of CRO to rapidly adapt to changing needs
Maintaining sufficient quality
What are the biggest challenges with implementing RBM? (Select top 3)
Source: Covance commissioned RBM study, 2013
More than regulatory questions holding back RBM
Confidential – For Internal Use Only
RBM Process Implementation
6
1ProtocolDesign
2Risk
Assessment
4Performance
Analytics
Feedback throughout study
3Monitoring
Plan
• Starts with designing out risk: protocol is the blueprint for quality• Start with the end in mind – reliable data withstanding Agency scrutiny
5Monitoring Interventions
6Issue
Resolution
Confidential – For Internal Use Only
Identify Critical Data / Processes
Protocol Quality by Design
Risk-based Site Selection
Proactive Risk Identification & Mitigation
Patient safety, data integrity & regulatory compliance
Intervention & Adaptation
Risk Factor Analytics
Demonstrated ‘State of Control’
Centralized Data Surveillance
Study Delivery
RBM Process Implementation, cont.
RBM Plan
Study Planning
7
Confidential – For Internal Use Only
Translating Risk into Action
8
Appropriate risk management requires a broad range of tools
Examples Management Approaches
Intrinsic risks
Maturity of safety profilePhase of development
Adjusted average site visit intervalAdjusted average SDV levelProportion remote/on site
Design risks
Clarity of protocolPrimary endpoint approachFit vs. standard of care
Quality by design improvementsCentral data surveillanceSupplementary training (site/CRA)
In-Flight Risks
Site experienceStaff turnoverAdverse event reporting levels
Adjusted site-specific intervention levelsTurnover management and training plansIssue management plans
Confidential – For Internal Use Only9
• Study/Program level focus
• Robust RBM solution a differentiator (+ or –)
• Impetus to develop
• Readiness to invest
• Operational excellence and process innovation in our DNA
• Critical need for flexibility and adaptability – Sponsor agnostic
SPONSOR CRO
Sponsor and CRO Perspectives
• Compound level focus, integrates with TPP
• Drivers for change vary
• Executive urgency for improved efficiency
• Functional conservatism and variable silos to overcome
• Opportunities to leverage CRO partners
9
Confidential – For Internal Use Only
Clinical Operations
StatisticsMedicalData Management
Data Management
Medical
Fit for Purpose Throughout the Continuum
Protocol Design
CRF Design Monitoring Data
CleaningMedical Review
Statistical Review
10
Start with the end in mind
Confidential – For Internal Use Only11
• Quality of critical data & processes enhanced through preferential focus
• Cost saving is a consequence of monitoring what matters
• Focus on Quality by Design and Risk, not SDV reduction
• Areas reduced are not critical from an outcome perspective
Functional View Holistic View
Overcoming Functional Barriers
• “RBM is all about clinical cost reduction”
• “Quality will suffer on variables not monitored” – risk prevention not considered
• “There is nothing wrong with how we’ve done things before”
• ‘Burning platform’ challenge is only for Clinical Operations
Focused change management
11
Confidential – For Internal Use Only
Implementation Learnings
• Variable needs and priorities• Tailored solution needed, consistent but flexible
Sponsor
• Managing monitor support expectations• Expectation-setting and alternative methodologies
Site
• Resource management• Change management• Access to information
Monitors
1212
Confidential – For Internal Use Only
Experiences from Implementation
13
• Ph III Pivotal Study• Reduced SDV• Targeted RMV
strategy• NDA/MAA approved
Example #2
• Cardiovascular outcomes study
• Full RBM Design• tSDV implemented• Ongoing, enrolling
Example #1
• Partner portfolio• ‘Fit-for-purpose’
monitoring• Tailored RMV/SDV• Multiple TA studies
Example #3
13
Confidential – For Internal Use Only
RBM Value Hierarchy
Protocol simplificationQuality-by-designRisk-based site selectionSystematic mitigationCentralized data surveillanceRisk-targeted on-site review
14
QUALTY
EFF I CI
ENCY
14
Ultimate aim – de-risking development
Confidential – For Internal Use Only
Impact of Efficiencies in Clinical Monitoring
15
Study Complexity
Cos
t/Effi
cien
cy v
s. T
radi
tiona
l Mon
itorin
g*
*Relates to clinical monitoring activities, not full study costs. Covance internal data
Confidential – For Internal Use Only16
• Fit for purpose quality
• Alignment with regulators
• Demonstrated state of control
• Timely delivery
• Improved efficiency
SPONSOR PRIORITIES CRO PRIORITIES
Mutually Beneficial Implementation
RBM can transform risks into returns• Effective, adaptive resources allocated targeting maximum impact and value
• Proactive planning and focus on primary quality and state of control
• Efficiency gains a consequence of fitness-for-purpose
• Fit for purpose quality
• Alignment with regulators
• Demonstrated state of control
• Timely delivery
• Improved efficiency
16
Confidential – For Internal Use Only
17
17
For more information, visit www.covance.com/RBM